Gap finder
Search review questions
Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Every word you type has to appear somewhere in the question, and the closest matches are ranked first.
15,213 questions in 2,394 reviews
current versionsNo studies 15,213 · 100%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
| Question | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Opioid vs diazepam Adverse events (treatment related) To discharge · newborn infants with opioid withdrawal Opioid treatment for opioid withdrawal in newborn infants (2021) · Cochrane | no estimate extracted | NR | No studies |
Opioid vs phenobarbital Neonatal or infant mortality · newborn infants with opioid withdrawal Opioid treatment for opioid withdrawal in newborn infants (2021) · Cochrane | no estimate extracted | NR | No studies |
Opioid vs phenobarbital Neurodevelopmental disability · newborn infants with opioid withdrawal Opioid treatment for opioid withdrawal in newborn infants (2021) · Cochrane | no estimate extracted | NR | No studies |
Opioid vs chlorpromazine Neonatal or infant mortality · newborn infants with opioid withdrawal Opioid treatment for opioid withdrawal in newborn infants (2021) · Cochrane | no estimate extracted | NR | No studies |
Opioid vs chlorpromazine Neurodevelopmental disability · newborn infants with opioid withdrawal Opioid treatment for opioid withdrawal in newborn infants (2021) · Cochrane | no estimate extracted | NR | No studies |
Opioid vs chlorpromazine Days hospitalisation · newborn infants with opioid withdrawal Opioid treatment for opioid withdrawal in newborn infants (2021) · Cochrane | no estimate extracted | NR | No studies |
Opioid vs placebo or no treatment / usual care Adverse events (treatment‐related) To discharge · newborn infants with opioid withdrawal Opioid treatment for opioid withdrawal in newborn infants (2021) · Cochrane | no estimate extracted | NR | No studies |
Morphine vs methadone Seizures · newborn infants with opioid withdrawal Opioid treatment for opioid withdrawal in newborn infants (2021) · Cochrane | no estimate extracted | NR | No studies |
High MCT formula vs low MCT formula Neurodevelopmental outcomes · promoting short‐term growth of preterm infants High versus low medium chain triglyceride content of formula for promoting short‐term growth of preterm… (2021) · Cochrane | no estimate extracted | NR | No studies |
High MCT formula vs low MCT formula Long‐term growth outcomes · promoting short‐term growth of preterm infants High versus low medium chain triglyceride content of formula for promoting short‐term growth of preterm… (2021) · Cochrane | no estimate extracted | NR | No studies |
Dipyridamole vs placebo Duration of hospital stay · people with ESRD receiving haemodialysis through an arteriovenous graft Medical adjuvant treatment to increase patency of arteriovenous fistulae and grafts (2021) · Cochrane | no estimate extracted | NR | No studies |
Dipyridamole vs placebo Number of related surgical or radiological interventions · people with ESRD receiving haemodialysis through an arteriovenous graft Medical adjuvant treatment to increase patency of arteriovenous fistulae and grafts (2021) · Cochrane | no estimate extracted | NR | No studies |
Dipyridamole plus aspirin vs placebo Duration of hospital stay · people with ESRD receiving haemodialysis through an arteriovenous graft Medical adjuvant treatment to increase patency of arteriovenous fistulae and grafts (2021) · Cochrane | no estimate extracted | NR | No studies |
Dipyridamole plus aspirin vs placebo Number of related surgical or radiological interventions · people with ESRD receiving haemodialysis through an arteriovenous graft Medical adjuvant treatment to increase patency of arteriovenous fistulae and grafts (2021) · Cochrane | no estimate extracted | NR | No studies |
Warfarin vs placebo Duration of hospital stay · people with ESRD receiving haemodialysis through an arteriovenous graft Medical adjuvant treatment to increase patency of arteriovenous fistulae and grafts (2021) · Cochrane | no estimate extracted | NR | No studies |
Aspirin vs placebo Duration of hospital stay · people with ESRD receiving haemodialysis through an arteriovenous fistula or graft Medical adjuvant treatment to increase patency of arteriovenous fistulae and grafts (2021) · Cochrane | no estimate extracted | NR | No studies |
Warfarin vs placebo Number of related surgical or radiological interventions · people with ESRD receiving haemodialysis through an arteriovenous graft Medical adjuvant treatment to increase patency of arteriovenous fistulae and grafts (2021) · Cochrane | no estimate extracted | NR | No studies |
Fish oil vs placebo Duration of hospital stay · people with ESRD receiving haemodialysis through an arteriovenous graft Medical adjuvant treatment to increase patency of arteriovenous fistulae and grafts (2021) · Cochrane | no estimate extracted | NR | No studies |
Clopidogrel vs placebo Duration of hospital stay · people with ESRD receiving haemodialysis through an arteriovenous fistula Medical adjuvant treatment to increase patency of arteriovenous fistulae and grafts (2021) · Cochrane | no estimate extracted | NR | No studies |
Sulphinpyrazone vs placebo Duration of hospital stay · people with ESRD receiving haemodialysis through an arteriovenous fistula or arteriovenous graft Medical adjuvant treatment to increase patency of arteriovenous fistulae and grafts (2021) · Cochrane | no estimate extracted | NR | No studies |
Sulphinpyrazone vs placebo Number of related surgical or radiological interventions · people with ESRD receiving haemodialysis through an arteriovenous fistula or arteriovenous graft Medical adjuvant treatment to increase patency of arteriovenous fistulae and grafts (2021) · Cochrane | no estimate extracted | NR | No studies |
Glyceryl trinitrate patch vs placebo Duration of hospital stay · people with ESRD receiving haemodialysis through an arteriovenous fistula Medical adjuvant treatment to increase patency of arteriovenous fistulae and grafts (2021) · Cochrane | no estimate extracted | NR | No studies |
Glyceryl trinitrate patch vs placebo Number of related surgical or radiological interventions · people with ESRD receiving haemodialysis through an arteriovenous fistula Medical adjuvant treatment to increase patency of arteriovenous fistulae and grafts (2021) · Cochrane | no estimate extracted | NR | No studies |
Aspirin vs placebo Number of related surgical or radiological interventions · people with ESRD receiving haemodialysis through an arteriovenous fistula or graft Medical adjuvant treatment to increase patency of arteriovenous fistulae and grafts (2021) · Cochrane | no estimate extracted | NR | No studies |
Ticlopidine vs placebo Duration of hospital stay · people with ESRD receiving haemodialysis through an arteriovenous fistula or graft Medical adjuvant treatment to increase patency of arteriovenous fistulae and grafts (2021) · Cochrane | no estimate extracted | NR | No studies |
Ticlopidine vs placebo Number of related surgical or radiological interventions · people with ESRD receiving haemodialysis through an arteriovenous fistula or graft Medical adjuvant treatment to increase patency of arteriovenous fistulae and grafts (2021) · Cochrane | no estimate extracted | NR | No studies |
Early discharge vs standard discharge Maternal mortality within 6 weeks ‐ not reported · healthy mothers and term infants Early postnatal discharge from hospital for healthy mothers and term infants (2021) · Cochrane | no estimate extracted | NR | No studies |
Macrolides vs placebo Outcomesa · adults and children with chronic asthma Macrolides versus placebo for chronic asthma (2021) · Cochrane | no estimate extracted | NR | No studies |
Comparison 1. Educational meetings as a single intervention or as the main component of a multi‐faceted intervention vs no intervention Compliance with desired practice (Yes/No ‐ dichotomous outcomes · health personnel Continuing education meetings and workshops: effects on professional practice and healthcare outcomes (2021) · Cochrane | no estimate extracted | NR | No studies |
Comparison 2. Educational meetings alone vs other interventions Compliance with desired practice (measured on a continuous scale) · health personnel Continuing education meetings and workshops: effects on professional practice and healthcare outcomes (2021) · Cochrane | no estimate extracted | NR | No studies |
Comparison 2. Educational meetings alone vs other interventions Patient outcomes · health personnel Continuing education meetings and workshops: effects on professional practice and healthcare outcomes (2021) · Cochrane | no estimate extracted | NR | No studies |
Comparison 3. Interactive educational meetings vs didactic (lecture‐based) educational meetings Compliance with desired practice (Yes/No ‐ dichotomous outcomes) · health personnel Continuing education meetings and workshops: effects on professional practice and healthcare outcomes (2021) · Cochrane | no estimate extracted | NR | No studies |
Comparison 3. Interactive educational meetings vs didactic (lecture‐based) educational meetings Compliance with desired practice (measured on a continuous scale) · health personnel Continuing education meetings and workshops: effects on professional practice and healthcare outcomes (2021) · Cochrane | no estimate extracted | NR | No studies |
Comparison 3. Interactive educational meetings vs didactic (lecture‐based) educational meetings Patient outcomes · health personnel Continuing education meetings and workshops: effects on professional practice and healthcare outcomes (2021) · Cochrane | no estimate extracted | NR | No studies |
Comparison 3. Interactive educational meetings vs didactic (lecture‐based) educational meetings Dichotomous · health personnel Continuing education meetings and workshops: effects on professional practice and healthcare outcomes (2021) · Cochrane | no estimate extracted | NR | No studies |
Comparison 3. Interactive educational meetings vs didactic (lecture‐based) educational meetings Continuous · health personnel Continuing education meetings and workshops: effects on professional practice and healthcare outcomes (2021) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Compliance with desired practice (Yes/No ‐ dichotomous outcomes) · health personnel Continuing education meetings and workshops: effects on professional practice and healthcare outcomes (2021) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Compliance with desired practice (measured on a continuous scale) · health personnel Continuing education meetings and workshops: effects on professional practice and healthcare outcomes (2021) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Patient outcomes · health personnel Continuing education meetings and workshops: effects on professional practice and healthcare outcomes (2021) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Dichotomous · health personnel Continuing education meetings and workshops: effects on professional practice and healthcare outcomes (2021) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Continuous · health personnel Continuing education meetings and workshops: effects on professional practice and healthcare outcomes (2021) · Cochrane | no estimate extracted | NR | No studies |
Comparison 1. Educational meetings as a single intervention or as the main component of a multi‐faceted intervention vs no intervention Compliance with desired practice (measured on a continuous scale) · health personnel Continuing education meetings and workshops: effects on professional practice and healthcare outcomes (2021) · Cochrane | no estimate extracted | NR | No studies |
Comparison 1. Educational meetings as a single intervention or as the main component of a multi‐faceted intervention vs no intervention Patient outcomes · health personnel Continuing education meetings and workshops: effects on professional practice and healthcare outcomes (2021) · Cochrane | no estimate extracted | NR | No studies |
Comparison 1. Educational meetings as a single intervention or as the main component of a multi‐faceted intervention vs no intervention Dichotomous · health personnel Continuing education meetings and workshops: effects on professional practice and healthcare outcomes (2021) · Cochrane | no estimate extracted | NR | No studies |
Comparison 1. Educational meetings as a single intervention or as the main component of a multi‐faceted intervention vs no intervention Continuous · health personnel Continuing education meetings and workshops: effects on professional practice and healthcare outcomes (2021) · Cochrane | no estimate extracted | NR | No studies |
Comparison 2. Educational meetings alone vs other interventions Compliance with desired practice (Yes/No ‐ dichotomous outcomes) · health personnel Continuing education meetings and workshops: effects on professional practice and healthcare outcomes (2021) · Cochrane | no estimate extracted | NR | No studies |
Intermittent oral levetiracetam vs placebo (any antipyretics) Recurrent seizures at 18 months · children with febrile seizures Prophylactic drug management for febrile seizures in children (2021) · Cochrane | no estimate extracted | NR | No studies |
Intermittent oral levetiracetam vs placebo (any antipyretics) Recurrent seizures at 24 months · children with febrile seizures Prophylactic drug management for febrile seizures in children (2021) · Cochrane | no estimate extracted | NR | No studies |
Intermittent oral levetiracetam vs placebo (any antipyretics) Recurrent seizures at 36 months · children with febrile seizures Prophylactic drug management for febrile seizures in children (2021) · Cochrane | no estimate extracted | NR | No studies |
Intermittent oral levetiracetam vs placebo (any antipyretics) Recurrent seizures at 48 months · children with febrile seizures Prophylactic drug management for febrile seizures in children (2021) · Cochrane | no estimate extracted | NR | No studies |